Suguru Shirotake - Concepedia

Author

Suguru Shirotake

Keio University ORCID

Also Known As

S Shirotake, S. Shirotake, SUGURU SHIROTAKE, Shirotake, Suguru, Suguru Shirotake, Suguru Shirotake (647777), Akio Asai

157

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Keio University Saitama Medical University Saiseikai Central Hospital Saitama Municipal Hospital National Hospital Organization

About

Suguru Shirotake is an author at Keio University specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	693
2	Cell Biology	3	3	105
3	Health Sciences	2	2	53
4	Immunology	2	2	60
5	Epidemiology	1	1	31

Suguru Shirotake

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer Ichiei Kuji, Tomohiko Yamane, Akira Seto, European Journal of Hybrid Imaging	2017	100
The Predictive Value of C-reactive Protein for Prognosis in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy: A Multi-institutional Study Nobuyuki Tanaka, Eiji Kikuchi, Suguru Shirotake, European Urology Prognostic BiomarkersUrologySurgical OncologyGenitourinary CancerMedicine	2012	80
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Annals of Surgical Oncology UrologySurgical OncologyGenitourinary CancerMedicinePrognostic Value	2014	76
The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Urologic Oncology Seminars and Original Investigations Urological ResearchUrologySurgical OncologyPositive Urine CytologyGenitourinary Cancer	2013	61
Long-Term Androgen Ablation and Docetaxel Up-Regulate Phosphorylated Akt in Castration Resistant Prostate Cancer Takeo Kosaka, Akira Miyajima, Suguru Shirotake, The Journal of Urology	2011	57
Expression of Snail in Upper Urinary Tract Urothelial Carcinoma: Prognostic Significance and Implications for Tumor Invasion Takeo Kosaka, Eiji Kikuchi, Shuji Mikami, Clinical Cancer Research	2010	57
Angiotensin II Type 1 Receptor Expression and Microvessel Density in Human Bladder Cancer Suguru Shirotake, Akira Miyajima, Takeo Kosaka, Urology UrologyOncologyMicrovessel DensityHuman Bladder CancerGenitourinary Cancer	2011	56
Metastatic Behavior of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: Association with Primary Tumor Location Nobuyuki Tanaka, Eiji Kikuchi, Kent Kanao, Annals of Surgical Oncology Urological ResearchUrologySurgical OncologyPrimary Tumor LocationMetastatic Behavior	2013	54
The pretreatment neutrophil-to-lymphocyte ratio is a novel biomarker for predicting clinical responses to pembrolizumab in platinum-resistant metastatic urothelial carcinoma patients Koichiro Ogihara, Eiji Kikuchi, Keisuke Shigeta, Urologic Oncology Seminars and Original Investigations Pretreatment Neutrophil-to-lymphocyte RatioPrognostic BiomarkersUrologyGenitourinary CancerClinical Responses	2020	54
Ets‐1 and hypoxia inducible factor‐1α inhibition by angiotensin II type‐1 receptor blockade in hormone‐refractory prostate cancer Takeo Kosaka, Akira Miyajima, Suguru Shirotake, The Prostate	2009	45

Page 1